Pliva Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PLIVA
PLIVA has seventy-six approved drugs.
There are six tentative approvals on PLIVA drugs.
Summary for Pliva
| US Patents: | 0 |
| Tradenames: | 46 |
| Ingredients: | 44 |
| NDAs: | 76 |
| Patent Litigation for Pliva: | See patent lawsuits for Pliva |
Drugs and US Patents for Pliva
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pliva | WARFARIN SODIUM | warfarin sodium | TABLET;ORAL | 040616-004 | Jul 5, 2006 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pliva | AZITHROMYCIN | azithromycin | TABLET;ORAL | 065225-001 | Nov 14, 2005 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pliva Lachema | IRINOTECAN HYDROCHLORIDE | irinotecan hydrochloride | INJECTABLE;INJECTION | 078122-002 | Oct 31, 2008 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
